![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 6, 4159-4165, February 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the
Department of Biochemistry and Molecular
Biology, University of Illinois at Chicago, Chicago, Illinois 60607 and
the § Department of Molecular Genetics, Max Planck Institute
for Biophysical Chemistry, Göttingen 37018, Germany
Received for publication, November 9, 2001
| |
ABSTRACT |
|---|
|
|
|---|
CASK is a member of the membrane-associated
guanylate kinases (MAGUK) homologs, a family of proteins that scaffold
protein complexes at particular regions of the plasma membrane by
utilizing multiple protein-binding domains. The GK domain of MAGUKs,
which shares high similarity in amino acid sequence with yeast
guanylate kinase (yGMPK), is the least characterized MAGUK domain both
in structure and function. In addition to its scaffolding function, the
GK domain of hCASK has been shown to be involved in transcription regulation. Here we report the crystal structure of the GK domain of
human CASK (hCASK-GK) at 1.3-Å resolution. The structure rationalizes the inability of the GK domain to catalyze phosphoryl transfer and
strongly supports its new function as a protein-binding module. Comparison of the hCASK-GK structure with the available crystal structures of yGMPK provides insight into possible
conformational changes that occur in hCASK upon GMP binding. These
conformational changes may act to regulate hCASK-GK function in a
nucleotide-dependent manner.
Membrane-associated guanylate kinases
(MAGUKs)1 constitute a newly
recognized class of proteins found in all animals examined to date.
They act as molecular scaffolds for signaling pathway components,
regulate synaptic structure and function by mediating specific
interactions, and (in Drosophila) act as tumor suppressors. In addition, MAGUKs recruit molecules into localized multimolecular complexes and cluster these complexes at the plasma membrane, such as
cell junctions or the apicolateral or basolateral surface, and pre- or
post-synaptic sites (1-6). All MAGUK proteins share a similar
multidomain structural organization that includes (from the N to C
termini) one or three copies of PDZ
(PSD-95/SAP-90-Dlg-Zo1) domains,
followed by one Src homology 3 (SH3) domain, then followed by a
guanylate kinase-like (GK) domain (3). The PDZ domain functions as a
protein-protein interaction module and is typically involved in the
assembly of supramolecular complexes that perform localized signaling
functions at particular subcellular locations (7). Although their
specific functions in MAGUKs are not very clear, SH3 domains are found
in many other proteins and are recognized as modular protein-protein
interaction domains with an affinity for certain proline-rich motifs
(8).
The GK domain in MAGUKs shares high sequence similarity with yeast
guanylate kinase (yGMPK), a nucleoside monophosphate kinase that
converts GMP to GDP using ATP as a phosphate donor. However, no
enzymatic activity is present in MAGUK GK domains. Moreover, several
protein binding partners of GK domains were found by yeast two-hybrid
screens or pull-down assays (see Table III below), and this suggested
that the GK domain functions as a protein-binding module. Although the
GK domain cannot catalyze phosphoryl transfer, it can bind nucleotides.
Binding studies have shown that the GK domain of SAP-90 binds GMP in
the micromolar range and ATP in the millimolar range (9). Although a GK
domain is present in all MAGUKs, there is remarkable divergence in
nucleotide-binding sites among the four MAGUK subfamilies (see Fig. 1
below): Lin2/CASK- and p55-like MAGUKs have nearly intact GMP- and
ATP-binding sites; Dlg/SAP-90- and SAP-97-like MAGUKs have conserved
GMP-binding sites but lack some residues in their ATP-binding site; the
ZO1-like MAGUKs lack some residues in both sites (3). The role of
nucleotide binding to the GK domain is unclear in the absence of any
enzymatic activity. Based on known nucleotide-dependent
conformational changes that were observed in several nucleoside
monophosphate kinases, we hypothesized that nucleotides could play a
regulatory role in GK function by inducing different conformations
between the nucleotide-free and nucleotide-bound forms
To test this hypothesis we commenced crystallographic studies of GK
domains from different MAGUKs. Here we report the 1.3-Å crystal
structure of the GK domain of human CASK (hCASK-GK). Comparison of this
structure, which is the first MAGUK GK domain elucidated to our
knowledge, with the structures of yGMPK with and without GMP reveals
important differences in the conformation of the GMP-binding region and
the LID region. The structure reveals the reasons hCASK-GK is not able
to catalyze phosphoryl transfer. Modeling of GMP into hCASK-GK strongly
supports the binding of GMP to hCASK-GK. The hCASK-GK crystal structure
and the hCASK-GK-GMP model here reveal how an enzyme has been converted
into a protein-binding module and suggest how binding to GMP could
regulate the conformational state of this module within multidomain proteins.
Cloning and Recombinant Expression of hCASK-GK--
A cDNA
encoding the GK domain from human CASK protein (hCASK-GK; Arg-734 to
Cys-909) was amplified by the polymerase chain reaction from a pCRII
plasmid (Invitrogen Corp.), containing a full-length cDNA of hCASK
(10), and cloned into a modified pGEX-2T (Amersham Biosciences, Inc.)
E. coli expression vector, which allowed insertion of
NdeI/BamHI-restricted fragments into its multiple
cloning site (11).
Protein Expression and Purification--
Escherichia
coli BL21(DE3) cells carrying the plasmid that contains the gene
encoding the hCASK-GK-GST fusion protein were induced by 0.1 mM isopropyl- Crystallization--
Crystals were obtained by the hanging-drop
method at 20 °C. One microliter of 4 M sodium formate
(the reservoir solution) was mixed with an equal volume of 15 mg/ml of
the protein in 50 mM Tris-HCl, pH 7.5, 200 mM
KCl, 5 mM MgCl2, 1 mM EDTA, and 10 mM dithiothreitol. Initial crystals were found after 2 weeks. Further crystals were obtained with microseeding.
Trigonal crystals appeared overnight and grew to a maximum size of
350 × 350 × 400 µm3 in 1 week. The Matthews
coefficient of 2.73 (55% solvent content) suggested a monomer as the
asymmetric unit (13). Seleno-methionine crystals were grown from
seleno-methionine containing hCASK-GK protein using the microseeding technique.
Data Collection--
Initial native diffraction data to 1.6-Å
resolution were collected on a RAXIS IIc image plate detector using
copper radiation from a RAXIS RU-200 rotation anode x-ray generator at
100 K. The cryoprotectant was mineral oil. Molecular replacement with
the yGMPK model failed, a fact explained by our structure of the
CASK-GK domain that reveals large differences and movement of the
GMP-binding region and LID region. MIR was tried but also failed due to
lack of isomorphism. Therefore, a MAD dataset was collected from a crystal grown from seleno-methionine-labeled protein at three different
wavelengths (inflection, maximum, and high energy) at the BIOCars
beamline BM-D in the Advanced Photon Source, Argonne National
Laboratory using a Quantum-4 charge-coupled device detector at 100 K. This seleno-methionine crystal was grown with continuous microseeding,
and it diffracted to 1.7 Å. In addition, a native dataset at 1.31 Å was also collected. The data were processed with DENZO/SCALEPACK
(14).
Structure Determination and Refinement--
The crystal
structure of hCASK-GK was solved using the MAD dataset collected from a
seleno-methionine crystal. At this stage the space group ambiguity
between p3121 and p3221 was solved, the
latter being the correct space group. All of the four selenium sites in
one hCASK-GK monomer were located by the program SOLVE (15). The
resulting phases were improved with DM (16). Automatic model
building was done with ARP (17). Manuel model adjustment was carried
out with the graphics package O (18). The structure was initially
refined with CNS (19) against the MAD data in the resolution range
12.0-1.7 Å. 10% data were used for Rfree calculations. The model was then refined against the higher resolution native data set. Following rigid-body, minimization, annealing, and
B-factor refinement, the model was checked with
2Fo Modeling of GMP into the Structure of hCASK-GK--
We modeled
GMP into the structure of hCASK-GK guided by the structure of yGMPK
with GMP (GMPKGMP). Based on the high similarity of
the CORE and GMP-binding regions between our hCASK-GK structure and
the GMPKGMP structure, we could align the two structures
once based on atoms only from the CORE region and once from atoms only from the GMP-binding region. We then made a chimera coordinate file from two hCASK-GK pdb files generated by these two
operations, i.e. the CORE (and LID) regions from the pdb
file after using the CORE regions for the superposition operation, and
the GMP-binding region from the pdb file generated by using only atoms
from the GMP-binding region for the superposition calculation. The
location of the GMP molecule is exactly where it was in the
GMPKGMP structure. Interactions between GMP and hCASK-GK
side chains were optimized by rotating the side chains around their
torsion angles.
Structure Determination of hCASK-GK--
Human CASK-GK (Fig.
1) crystallizes in the hexagonal space
group P3221 with one molecule in the asymmetric unit. The
structure (Fig. 2) was solved using the
multiwavelength anomalous diffraction method (MAD) (21). Data
collection and phasing statistics can be found in Table
I. The experimental electron density map
was of very high quality, and the program ARP was successful in
automatically building most of the hCASK-GK model (Fig.
3A). After manual rebuilding with the 1.7-Å MAD dataset, the resolution was extended by using the
native 1.31-Å dataset. The final structure of hCASK-GK consists of 175 residues, 5 formate ions, and 218 water molecules. The N-terminal
residues 730 and 731 (Gly-Ser) and residues 774-776 (Lys-Lys-Asp) did
not have good electron density so were not modeled. The final
crystallographic R-factor is 18.6%
(Rfree = 21.2%) for all the reflections within
the resolution range 12.0-1.31 Å. Refinement statistics are shown in
Table I.
Overall Structure--
The fold of hCASK-GK is similar to that of
the yeast guanylate kinase (yGMPK) and, in a similar manner to the
latter, can be divided into three dynamic regions (Fig. 2). The CORE
region is built by five parallel Comparison between the Structures of hCASK-GK and
yGMPK--
Comparison of the hCASK-GK structure with the yeast
guanylate kinase was performed against the ligand-free yGMPK
(GMPKapo) and the GMP-bound yGMPK structures
(GMPKGMP). For the structural alignment of the three
structures, we only used atoms in the CORE region for the calculation
of the transformation matrices. The result of these operations is shown
in Fig. 3B. The CORE region of hCASK-GK shows high
similarity to that of GMPKapo and GMPKGMP (Fig.
4A). For the 91 C
However, the deviations between the other regions are pronounced. These
deviations are due to conformational changes by which the GMP-binding
region and the LID region move as rigid bodies relative to the CORE
region. Using atoms only from the CORE domain for the superposition
calculation shows that the GMP-binding region of hCASK-GK is positioned
between the conformation it adopts in the open GMPKapo
structure and the closed conformation in the GMPKGMP
structure (Fig. 3B). However, if one performs the alignment using only the atoms from the GMP-binding region (Fig. 4B),
the resulting structural overlay reveals that the basic structure of
the GMP-binding region is nearly identical between all three structures
(r.m.s.d. is 0.719 Å between hCASK-GK and GMPKapo and 0.802 Å between hCASK-GK and GMPKGMP for the 45 C
The above operation for the superposition of the GMP-binding regions
can be repeated for the LID regions, but the result is very different.
Not surprisingly, the LID of yeast guanylate kinase in the apo- and
GMP-bound structures overlay with a very low r.m.s.d. However, the
shorter LID region of hCASK adopts a very different conformation from
that of the enzyme guanylate kinase (Fig. 4C). The LID
region of GMPKapo and GMPKGMP is composed of
two helices connected by a loop, whereas the LID region of hCASK-GK is
composed of only a single helix and a long loop. The overlay done by
using the CORE region to align the structures shows that the LID region of hCASK-GK cannot be superimposed on the LID regions of
GMPKapo or GMPKGMP (Fig. 3B).
Moreover, even if the calculation of the superposition matrix is
performed using the most similar feature between the LID regions, the
Modeling of GMP Binding into the Structure of hCASK-GK--
Our
structure of hCASK-GK does not contain the nucleotide GMP. In
vitro binding studies of SAP-90 and SAP-97 have shown that GMP can bind to the GK domain (9, 23). Modeling of GMP binding to
hCASK-GK was guided by the hypothesis that upon GMP binding the
conformation of hCASK-GK would change to a more closed one, as was seen
upon binding of GMP to yGMPK. Using the GMPKGMP structure as a guide, we were able to model the expected closed conformation of
hCASK-GK (Fig. 5A). In our
model of GMP-bound hCASK-GK, the main difference with the yGMPK
GMP-bound structure is the position and fold of the LID region. Both
the CORE region and the GMP-binding region overlay well. Except for
residues Ser-34 and Arg-41, all other residues observed to interact
with GMP in the GMPKGMP structure are found almost at the
same position in the hCASK-GK-GMP model. The apparent lack of a residue
that would correspond to Arg-41 of yGMPK can be explained by the fact
that we could not observe traceable electron density for residues
774-776 of hCASK-GK. Lysine 774, which is not present in our model,
would correspond to Arg-41 of yGMPK. Our inability to model the above
loop is consistent with the expectation that this loop would become
more ordered once GMP binds to hCASK-GK. Fig. 5B shows the
superposition of the residues responsible for GMP binding in
GMPKGMP and in our hCASK-GK-GMP model. The expected
interactions between GMP and hCASK-GK are listed in Table
II.
An impressive amount of information on the
structural and functional networks that underlie neuronal activity has
recently accumulated through proteomic approaches to the
analysis of the molecular basis of synaptic signaling pathways (24,
25). A large number of proteins identified in signaling complexes,
neuromuscular junctions, and cell-cell contact sites contain
characteristic regions such as SH3 and PDZ domains. These domains
mediate specific protein-protein interactions and form scaffolds for
protein networks at specialized regions of the cell membranes. The
MAGUK family constitutes a major group of conserved cytoskeletal
proteins that consist of arrayed modular domains: one to three PDZ
domains, an SH3 domain, and, as a signature motif, a C-terminal
guanylate kinase-like domain. Whereas SH3 domains have a well-known
role as protein interaction modules in other systems (26), and PDZ domains were recognized as adapters for clustering of transmembrane or
membrane-associated proteins at high local concentrations (7, 27), the
role of the GK domain has until recently been mysterious, given the
fact that it has no enzymatic activity.
Several protein binding partners of GK domains were found by yeast
two-hybrid screens or pull-down assays (Table
III), and this suggested that the GK
domain functions as a protein binding module. Remarkably, several
MAGUKs and interacting proteins have additional, recently discovered
biological functions: GAKIN is a member of the kinesin superfamily of
motor proteins, and its interaction with the GK domain seems to play a
vital role in the intracellular trafficking of hDlg (28). CASK, a
member of the Lin2-like MAGUKs, has a transcription regulation function
through interaction of its GK domain with Tbr-1, a T-box transcription factor that is involved in forebrain development (29). The GK domain is
also involved in inter- and intramolecular interaction with MAGUK's
SH3 domain, and this intramolecular interaction regulates SAP-97
binding to GKAP and PSD-95/SAP-90 clustering of ion channels (30-33).
In addition, it is known that the Drosophila Dlg protein, the prototype member of the MAGUK family, is required in the
maintenance of septate junctions and epithelial structure; mutations in
the SH3 and GK domains of the protein are oncogenic in larval
development, and deletions in the GK domain cause loss of normal growth
without affecting epithelial structure (34-36). Similarly, the GK
domains of murine Dlg/SAP-97 and of CASK are essential to craniofacial and palatal morphogenesis in mice (37). Because these interactions and
functions were shown to be restricted to the GK domains of the
respective MAGUK subfamilies, it can be assumed that their specificity
is determined by subtle differences in GK domain structures. The high
resolution structure of the CASK GK domain we present in this study
will allow to gain insights into the molecular basis of the distinct
mechanisms for the interactions between the GK domains and their
binding partners.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside for
6 h at 25 °C in 2YT media. Cells were harvested by
centrifugation and lysed with lysozyme, and the supernatant after
ultracentrifugation was applied to a glutathione
S-transferase-Sepharose column pre-equilibrated with 50 mM Tris-HCl, pH 7.5, 200 mM KCl, 5 mM MgCl2, 1 mM EDTA, and 10 mM dithiothreitol. After washing, the fusion protein was cleaved on the column with thrombin for about 24 h. The
flow-through was collected and further purified to homogeneity by using
an ion exchange column (WP-QUAT) and gel filtration (Superdex-75). The
protein was concentrated by ultrafiltration to 25 mg/ml. Because of the
construction of a thrombin cleavage site at the N-terminal of hCASK-GK,
the resultant protein after cleavage has four additional amino acids
(Gly-Ser-His-Met-) at the N terminus. For seleno-methionine-containing protein, the plasmid was transformed into the methionine auxotroph E. coli strain B834(DE3), and the cells were grown and
induced as described previously (12). Purification was conducted as with the non-labeled protein. Incorporation of seleno-methionine at all four positions was confirmed by mass spectroscopy.
Fc and
Fo
Fc maps. After several iterations of refinement with CNS, anisotropic B-factor
refinement was done with REFMAC5.0 (20). Coordinates and structure
factors were being deposited in the Protein Data Bank (PDBID
1KGD).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (61K):
[in a new window]
Fig. 1.
Sequence alignment of the GK domain of MAGUKs
and yGMPK. The alignment was done using the Multalin Interface
Page and further edited manually (39). The glycine-rich ATP binding
motif and residues responsible for binding of guanine ring (
),
phosphates (*) of GMP, and for binding of Mg2+(+) are boxed
as well as the residues involved in catalysis (Arg-135, Arg-146, and
Asn-168 in yGMPK,
) and the residue responsible for ATP binding
(Arg-131).

View larger version (47K):
[in a new window]
Fig. 2.
Overall structure of hCASK-GK.
Green represents the CORE region, strands
1,
2,
7,
8, and
9, and helices
1,
3,
4, and
6.
Red, the GMP-binding region, composed of
3,
4,
5,
6, and helix
2. Blue, the LID region, helix
5.
Structural figures were generated with BOBSCRIPT (40) and RASTER3D
(41).
Summary of data collection, phasing, and refinement statistics

View larger version (61K):
[in a new window]
Fig. 3.
Stereoviews. A, a fragment of
the experimental electron density map of hCASK-GK (1.7-Å resolution)
contoured at 1.5
shown superimposed with the final structure.
B, overlay of the complete hCASK-GK (red),
GMPKapo (blue), and GMPKGMP
(cyan) structures. The superposition matrices were
calculated using only the C
atoms of the CORE region.
-strands and four
-helices. This
region is flanked by the GMP-binding region (red) and the
LID region (blue). The former is composed of a four-stranded
-sheet and a single
-helix, whereas the LID is seven residues
shorter than in yGMPK and is composed of a long loop and one
-helix.
The division of hCASK-GK into these three regions was guided by
comparing our structure to known structures of yGMPK such that each
region can move as a rigid body relative to the other regions.
Therefore, our choice of regions is slightly different than those
previously chosen for yGMPK, especially for the LID region (22). We
have chosen helix
-5 to be a part of the LID region and not the CORE region, because it adopts a quite different conformation and position in hCASK from that in yGMPK.
atoms
used for alignment, the root mean square deviation (r.m.s.d.) is 2.368 and 2.462 Å between hCASK-GK and GMPKapo and
GMPKGMP, respectively.

View larger version (32K):
[in a new window]
Fig. 4.
Stereoview of a C
trace of the overlaid different regions of hCASK-GK,
GMPKapo, and GMPKGMP generated by using the
C
atoms of the different regions.
Red, hCASK-GK; blue, GMPKGMP;
cyan, GMPKapo. A, the overlaid CORE
regions of hCASK-GK, GMPKapo, and GMPKGMP
generated by using the C
atoms of the CORE region of the three
structures. B, the overlaid GMP-binding regions of hCASK-GK,
GMPKapo, and GMPKGMP generated by using the
C
atoms of the GMP-binding region of the three structures.
C, the overlaid LID regions made by using only C
atoms of
the helix in the LID region of the three structures. The LID region of
hCASK is fundamentally different from that of yGMPK, and that observed
difference is not a result of a simple rigid-body movement.
atoms). This was previously demonstrated for the two yGMPK structures
(22), and our result shows that the GK domain of hCASK maintains a
nearly identical GMP-binding region to that of yGMPK, albeit it is in a
different conformation relative to the CORE region from those previously observed for GMPKapo or GMPKGMP.
Because in our structure of hCASK-GK the nucleotide GMP is absent, our
result suggests an attractive mechanism in which the function of MAGUKs
may be regulated.
-helix, no good superposition is obtained (Fig. 4C).
Thus, unlike the difference in structure between the GMP-binding region
of hCASK-GK and yGMPK, which can be explained by a rigid-body
conformational change, the LID region of hCASK is structurally distinct
from that of yGMPK. This fact serves to explain the apparent inability
of hCASK-GK to catalyze phosphoryl transfer (see "Discussion") and
of the MAGUK SAP-97 even after reconstituting the P-loop region
(23).

View larger version (45K):
[in a new window]
Fig. 5.
Modeling of GMP into the hCASK-GK
structure. A, stereoview of the GMPKGMP
(cyan) structure overlaid with the model GMP-bound hCASK-GK
(red and purple). For details on model generation
see the "Experimental Procedures." The black arrow shows
the expected conformational change that would occur in hCASK-GK upon
GMP binding. B, superposition of the GMP-binding sites in
the GMP-bound model of hCASK-GK (pink) and
GMPKGMP (cyan). The residues of hCASK-GK are
labeled. See also Table II.
Interactions between GMP and hCASK (modeled) and yGMPK
apart.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Binding partners of GK domain of different MAGUKs
Despite having only 27% sequence identity with yGMPK, the structure of hCASK-GK shows that the CORE and GMP-binding regions are markedly similar. The most apparent difference between the two proteins is the LID region, a region that in the enzyme yGMPK contains essential residues for catalysis. Similarly, the essential role of particular arginine residues from the LID region was highlighted in our previous work on thymidylate kinase (11, 38). LID region yGMPK arginines play a role in ATP binding (Arg-131) and in stabilizing the phosphate groups of ATP in the catalytic transition state (Arg-135 and Arg-146). None of the MAGUKs retain all of these three arginines (Fig. 1). The LID region of hCASK-GK has only a single arginine (Arg-869), which the structure-based sequence alignment suggests could correspond to the catalytic Arg-146 of yGMPK. However, the structure of hCASK-GK reveals that this arginine extends toward a totally different direction from that of Arg-146 observed in the structures of yGMPK. This is unlikely due to the lack of nucleotide in our hCASK-GK structure because this residue adopts a similar orientation in both the apo- and GMP-bound yGMPK structures. This shows that the LID region of hCASK-GK is deficient in residues essential for catalyzing phosphoryl transfer. Importantly, our structures show no other residues from other parts of the molecule that could compensate for the lack of these arginine residues. Therefore, our structural analyses yield an explanation for the lack of guanylate kinase activity of the GK domain of MAGUKs.
Although it is now understood why the GK domain cannot catalyze phosphoryl transfer, the question remains: Can it bind ATP or GMP? Our equilibrium binding assays show that hCASK-GK binds GMP with a dissociation constant of 0.3 µM but binds ATP with a dissociation constant greater than 10 mM.2 These results are consistent with our structure analyses that explain the low affinity for ATP. Although hCASK-GK has a nearly complete conserved P-loop motif, several facts suggest that the P-loop is not competent to bind ATP. First, the strictly conserved lysine of the P-loop motif is absent. In hCASK, this residue is an arginine. Alignment of all known guanylate kinase sequences reveals strict conservation of the P-loop lysine. Second, the serine/threonine that follows the lysine in the P-loop motif is replaced by an arginine residue in hCASK. The role of a serine or threonine residue of the P-loop sequence is to participate in ATP binding by donating its hydroxyl side chain as a ligand to the magnesium ion that invariably accompanies ATP. The replacement of such a residue with an arginine in hCASK precludes the ability of coordinating the magnesium ion. But perhaps more importantly, modeling of ATP in the hCASK-GK model (data not shown) reveals that the presence of the larger arginine side chain is not compatible with ATP binding. Third, hCASK-GK does not possess the arginine that would correspond to Arg-131 of yGMPK in the LID region. The function of this residue in yGMPK (and many other ATP-binding proteins) is to bind and position ATP by stacking against the adenine ring. Lastly, main-chain residues 891 and 892 from the CORE region of hCASK-GK, which correspond to residues 169 and 170 in yGMPK and participate in ATP binding, are not at the appropriate position to contribute to ATP binding. Although a conformational change of these residues to a more productive position for ATP interactions cannot be ruled out, this is unlikely because these residues are in the CORE region, which is rather rigid as exemplified by our comparison to yGMPK (see "Results"). Collectively, the above analysis presents a strong case against the ability of the P-loop like sequence of hCASK to act as a true P-loop and bind ATP. Thus, the low affinity binding of ATP to hCASK-GK can only be explained by ATP binding to the GMP-binding site.
Because hCASK-GK has an almost conserved GMP-binding site and it does bind GMP in equilibrium binding assays, we modeled GMP into the structure of hCASK-GK after a movement of the GMP-binding region based on the structure alignment between hCASK-GK and GMPKGMP. After minor adjustment of side chains of some residues, most of the interactions observed between GMP and yGMPK in the GMPKGMP structure could be duplicated (Table II). The replacement of Ser-34 of yGMPK by a proline residue in hCASK-GK does not preclude GMP binding. Consistent with the absence of GMP bound to hCASK in our structure is the apparent disorder of residues 774-776, which are predicted to participate in GMP binding. Such binding usually leads to stabilization of relevant residues. Thus, our structure supports the results of in vitro binding studies. Extensive attempts at obtaining crystals that contain the complex between hCASK-GK and GMP failed. This observation is consistent with a GMP-induced conformational change in the GK domain that resulted in a species that unfortunately was not amenable for crystallization.
In conclusion, the structure of hCASK-GK reveals the similarities and
differences between what has evolved to become a protein-binding module
and its enzymatic predecessor. The lack of enzymatic activity, the weak
ATP binding, and the high affinity to GMP is rationalized. The binding
of GMP to hCASK-GK can be of high functional relevance by inducing
conformational changes that serve to regulate MAGUKs, i.e.
to influence the intermolecular interaction between GKAP and SAP-97 GK
domain, between Tbr-1 and the CASK GK domain, or to influence the
intramolecular interaction between the SH3 domain and the GK domain of
SAP-97 and PSD95/SAP-90. If binding of GMP serves to regulate this
inter- or intramolecular interaction, a possible mechanism would exist
to regulate association of MAGUKs with various binding partners. This
first structure of a MAGUK GK domain provides us with an example of a
protein that has lost its enzymatic activity but maintained its ability
to adjust its conformation upon ligand binding. The structural features
shown by hCASK-GK may be common among other MAGUKs and are probably required for their function and regulation.
| |
ACKNOWLEDGEMENT |
|---|
We thank J. Anderson for stimulating discussions and suggestions.
| |
FOOTNOTES |
|---|
* This work was supported by Human Frontier Science Program Grant RG0120/1999-B (to Y. L. and I. P.). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. W-31-109-Eng-38. Use of the BioCARS Sector14 was supported by the National Institutes of Health, National Center for Research Resources, under Grant RR07707.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1KGD) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Illinois at Chicago, 1819 West Polk St., Chicago, IL 60612. Tel.: 312-355-5029; Fax: 312-355-4535; E-mail: lavie@uic.edu.
Published, JBC Papers in Press, November 29, 2001, DOI 10.1074/jbc.M110792200
2 O. Spangenberg, I. Paarmann, and M. Konrad, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MAGUK, membrane-associated guanylate kinase; PDZ, PSD-95/SAP-90-Dlg-Zo1 domain; SH3, Src homology 3; GK, guanylate kinase-like domain; yGMPK, yeast guanylate kinase; hCASK-GK, GK domain of human CASK; r.m.s.d., root mean square deviation; MAD, multiwavelength anomalous diffraction method.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, J. M. (1996) Curr. Biol. 6, 382-384[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | De Lorenzo, C., Mechler, B. M., and Bryant, P. J. (1999) Cancer Metastasis Rev. 18, 295-311[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Dimitratos, S. D., Woods, D. F., Stathakis, D. G., and Bryant, P. J. (1999) Bioessays 21, 912-921[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Fujita, A., and Kurachi, Y. (2000) Biochem. Biophys. Res. Commun. 269, 1-6[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Gonzalez-Mariscal, L., Betanzos, A., and Avila-Flores, A. (2000) Semin. Cell Dev. Biol. 11, 315-324[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Stevenson, B. R., and Keon, B. H. (1998) Annu. Rev. Cell Dev. Biol. 14, 89-109[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Sheng, M., and Sala, C. (2001) Annu. Rev. Neurosci. 24, 1-29[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Guruprasad, L., Dhanaraj, V., Timm, D., Blundell, T. L., Gout, I., and Waterfield, M. D. (1995) J. Mol. Biol. 248, 856-866[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Kistner, U., Garner, C. C., and Linial, M. (1995) FEBS Lett. 359, 159-163[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Cohen, A. R.,
Woods, D. F.,
Marfatia, S. M.,
Walther, Z.,
Chishti, A. H.,
Anderson, J. M.,
and Wood, D. F.
(1998)
J. Cell Biol.
142,
129-138 |
| 11. |
Brundiers, R.,
Lavie, A.,
Veit, T.,
Reinstein, J.,
Schlichting, I.,
Ostermann, N.,
Goody, R. S.,
and Konrad, M.
(1999)
J. Biol. Chem.
274,
35289-35292 |
| 12. | Doubie, S. (1997) 276, 523-557 |
| 13. | Matthews, B. W. (1968) J. Mol. Biol. 33, 491-497[Medline] [Order article via Infotrieve] |
| 14. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 15. | Terwilliger, T. C., and Berendzen, J. (1999) Acta Crystallogr. Sect. D Biol. Crystallogr. 55, 849-861[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Cowtan, K. (1994) 31, 34-38 |
| 17. | Perrakis, A., Sixma, T. K., Wilson, K. S., and Lamzin, V. S. (1997) Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 448-455[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard. (1991) Acta Crystallogr. Sect. A 47, 110-119 |
| 19. | Brunger, A., and Rice, L. (1997) Methods Enzymol. 277, 243-269[Medline] [Order article via Infotrieve] |
| 20. | Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 240-255[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Hendrickson, W., and Ogata, C. (1997) Methods Enzymol. 277, 494-523 |
| 22. | Blaszczyk, J., Li, Y., Yan, H., and Ji, X. (2001) J. Mol. Biol. 307, 247-257[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Kuhlendahl, S., Spangenberg, O., Konrad, M., Kim, E., and Garner, C. C. (1998) Eur. J. Biochem. 252, 305-313[Medline] [Order article via Infotrieve] |
| 24. | Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., and Grant, S. G. (2000) Nat. Neurosci. 3, 661-669[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Husi, H., and Grant, S. G. (2001) Trends Neurosci. 24, 259-266[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Pawson, T.,
and Scott, J. D.
(1997)
Science
278,
2075-2080 |
| 27. | Garner, C. C., Nash, J., and Huganir, R. L. (2000) Trends Cell Biol. 10, 274-280[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Hanada, T.,
Lin, L.,
Tibaldi, E. V.,
Reinherz, E. L.,
and Chishti, A. H.
(2000)
J. Biol. Chem.
275,
28774-28784 |
| 29. | Hsueh, Y. P., Wang, T. F., Yang, F. C., and Sheng, M. (2000) Nature 404, 298-302[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
McGee, A. W.,
and Bredt, D. S.
(1999)
J. Biol. Chem.
274,
17431-17436 |
| 31. |
Nix, S. L.,
Chishti, A. H.,
Anderson, J. M.,
and Walther, Z.
(2000)
J. Biol. Chem.
275,
41192-41200 |
| 32. |
Shin, H.,
Hsueh, Y. P.,
Yang, F. C.,
Kim, E.,
and Sheng, M.
(2000)
J. Neurosci.
20,
3580-3587 |
| 33. | Wu, H., Reissner, C., Kuhlendahl, S., Coblentz, B., Reuver, S., Kindler, S., Gundelfinger, E. D., and Garner, C. C. (2000) EMBO J. 19, 5740-5751[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Woods, D. F., and Bryant, P. J. (1991) Cell 66, 451-464[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Woods, D. F.,
Hough, C.,
Peel, D.,
Callaini, G.,
and Bryant, P. J.
(1996)
J. Cell Biol.
134,
1469-1482 |
| 36. | Thomas, U., Ebitsch, S., Gorczyca, M., Koh, Y. H., Hough, C. D., Woods, D., Gundelfinger, E. D., and Budnik, V. (2000) Curr. Biol. 10, 1108-1117[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Caruana, G.,
and Bernstein, A.
(2001)
Mol. Cell. Biol.
21,
1475-1483 |
| 38. |
Lavie, A.,
Ostermann, N.,
Brundiers, R.,
Goody, R. S.,
Reinstein, J.,
Konrad, M.,
and Schlichting, I.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14045-14050 |
| 39. |
Corpet, F.
(1988)
Nucleic Acids Res.
16,
10881-10890 |
| 40. | Esnouf, R. M. (1997) J. Mol. Graph. Model. 15, 132-134[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Merritt, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524[Medline] [Order article via Infotrieve] |
| 42. | Zhang, Y., Luan, Z., Liu, A., and Hu, G. (2001) FEBS Lett. 497, 99-102[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Pak, D. T., Yang, S., Rudolph-Correia, S., Kim, E., and Sheng, M. (2001) Neuron 31, 289-303[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Takeuchi, M.,
Hata, Y.,
Hirao, K.,
Toyoda, A.,
Irie, M.,
and Takai, Y.
(1997)
J. Biol. Chem.
272,
11943-11951 |
| 45. | Satoh, K., Yanai, H., Senda, T., Kohu, K., Nakamura, T., Okumura, N., Matsumine, A., Kobayashi, S., Toyoshima, K., and Akiyama, T. (1997) Genes Cells 2, 415-424[Abstract] |
| 46. |
Kim, E.,
Naisbitt, S.,
Hsueh, Y. P.,
Rao, A.,
Rothschild, A.,
Craig, A. M.,
and Sheng, M.
(1997)
J. Cell Biol.
136,
669-678 |
| 47. |
Deguchi, M.,
Hata, Y.,
Takeuchi, M.,
Ide, N.,
Hirao, K.,
Yao, I.,
Irie, M.,
Toyoda, A.,
and Takai, Y.
(1998)
J. Biol. Chem.
273,
26269-26272 |
| 48. |
Brenman, J. E.,
Topinka, J. R.,
Cooper, E. C.,
McGee, A. W.,
Rosen, J.,
Milroy, T.,
Ralston, H. J.,
and Bredt, D. S.
(1998)
J. Neurosci.
18,
8805-8813 |
| 49. |
Fanning, A. S.,
Jameson, B. J.,
Jesaitis, L. A.,
and Anderson, J. M.
(1998)
J. Biol. Chem.
273,
29745-29753 |
This article has been cited by other articles:
![]() |
O. Olsen and D. S. Bredt Functional Analysis of the Nucleotide Binding Domain of Membrane-associated Guanylate Kinases J. Biol. Chem., February 21, 2003; 278(9): 6873 - 6878. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Manning, D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The Protein Kinase Complement of the Human Genome Science, December 6, 2002; 298(5600): 1912 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Paarmann, O. Spangenberg, A. Lavie, and M. Konrad Formation of Complexes between Ca2+{middle dot}Calmodulin and the Synapse-associated Protein SAP97 Requires the SH3 Domain-Guanylate Kinase Domain-connecting HOOK Region J. Biol. Chem., October 18, 2002; 277(43): 40832 - 40838. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||